This article relies largely or entirely on a single source. (May 2022) |
Clinical data | |
---|---|
Other names | M1T; SC-11195; Methyldihydroboldenone; 17α-Methyl-1-testosterone; 17α-Methyl-4,5α-dihydro-δ1-testosterone; 17α-Methyl-δ1-DHT; 17α-Methyl-5α-androst-1-en-17β-ol-3-one |
Routes of administration | By mouth |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.219.594 |
Chemical and physical data | |
Formula | C20H30O2 |
Molar mass | 302.458 g·mol−1 |
3D model (JSmol) | |
| |
|
Methyl-1-testosterone (M1T; developmental code name SC-11195), also known as 17α-methyl-4,5α-dihydro-δ1-testosterone (17α-methyl-δ1-DHT) or 17α-methyl-5α-androst-1-en-17β-ol-3-one, as well as methyldihydroboldenone, is a synthetic and orally active anabolic–androgenic steroid (AAS)[1] which was never marketed for medical use. It is the 17α-methyl derivative of 1-testosterone (Δ1-DHT; dihydroboldenone).
Methyl-1-testosterone is on the World Anti-Doping Agency's list of prohibited substances,[2] and is therefore banned from use in most major sports.